Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire The Binding Site Group Ltd. from Nordic Capital and Five Arrows Managers SAS for $2.3 billion on October 31, 2022. Upon completion, The Binding Site Group will become part of the Specialty Diagnostics segment. The transaction, which is expected to be completed in the first half of 2023, is subject to customary closing conditions, including regulatory approvals. Transaction is expected to be accretive to adjusted earnings per share.

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of The Binding Site Group Ltd. from Nordic Capital and Five Arrows Managers for $2.7 billion on January 3, 2023. As part of the transaction, Thermo Fisher Cash paid $2.4 billion, Debt settled of $307 million, and Cash acquired of $19 million. Linklaters LLP acted as financial advisor to Thermo Fisher Scientific Inc.